BackExascale Labs Holdings Overview

Exascale Labs Holdings EBIT

Latest ebit for XLAB: $-810K, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$0.00

As of Jun 30, 2026

Annual EBIT (TTM)

-$810.98K

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Exascale Labs Holdings (XLAB) FAQ

The latest EBIT for XLAB is $-810K as of June 2026. That is below the sector sector average of $2.4T. Investors often review this figure alongside Exascale Labs Holdings's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, XLAB currently prints $-810K for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Exascale Labs Holdings's growth, margins, and balance sheet.

A EBIT figure of $-810K for XLAB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting XLAB's EBIT ($-810K), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.